Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease
Abstract Recently, there has been an increasing interest in the therapeutic efficacy of RAS inhibitors (RASi) in patients with non-alcoholic fatty liver disease (NAFLD) because they may reduce oxidative stress, inflammatory markers, and enhanced fibrosis. An objective of this study was to investigat...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/648294fd0b844a61a38cb4f6b5afa69b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|